Aptose Biosciences Inc (APTO)

[Zeppo]

The stock has dropped from the .60 area to the .49 area. That means, after the reverse split, the stock will trade lower automatically from where it traded a few short weeks ago. The long term ramifications are the same for APTO as they are for any company effecting a reverse split. Usually, low priced stocks are given a short term shot in the arm by maintaining their NASDAQ status above $1.00. The problem is the prospect for future revenues. This company can't even decide which dosage to take to Phase III. The longer it drags out and revenues are delayed, the lower the stock price will be.....yes even after the reverse split. I have seen only two reverse splits work out for shareholders over a 30+ year span.